Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes
Manon Desmares, Marion Delphin, Brieux Chardès, Caroline Pons, Juliette Riedinger, Maud Michelet, Michel Rivoire, Bernard Verrier, Anna Salvetti, Julie Lucifora, David Durantel
Topics & Concepts
cccDNAInnate immune systemHBsAgHepatitis B virusAgonistBiologyTLR7TLR3VirologyImmunologyReceptorPattern recognition receptorImmune systemInterferonPharmacologyToll-like receptorVirusBiochemistryHepatitis B Virus StudiesImmune Response and InflammationHepatitis C virus research